DDIT3 and cancer: Combination treatment with SERCA inhibitors and anti-cancer drugs significantly induced the expression of CHOP, an ER stress marker, in drug-resistant HCC cells, while calcium channel blockers alone or combined with anti-cancer drugs had no significant effect on drug-resistant HCC cells (Figure 5O–S).